SCHEMBL7963386

SCHEMBL7963386

CCOC(=O)CCCOc1ccc2c(c1)c(CC(N)=O)c(C)n2Cc1ccccc1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953375 0.93 PLA2G2A (1.00) PLA2G2A
SCHEMBL7965509 0.92 PLA2G2A (0.82) PLA2G2A
SCHEMBL7965400 0.91 PLA2G2A (0.81) PLA2G2A
SCHEMBL7697040 0.91 PLA2G2A (0.71) PLA2G2A
SCHEMBL4317828 0.91 PLA2G2A (1.00) PLA2G2A
SCHEMBL24353497 0.90 PLA2G2A (0.85) PLA2G2A
SCHEMBL8299244 0.90 PLA2G2A (0.83) PLA2G2A
SCHEMBL7963277 0.90 PLA2G2A (1.00) PLA2G2A
SCHEMBL7953513 0.90 PLA2G2A (0.81) PLA2G2A
SCHEMBL7963976 0.89 PLA2G2A (0.86) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 EP disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed